First Bank & Trust Sells 814 Shares of Stevanato Group S.p.A. (NYSE:STVN)

First Bank & Trust decreased its holdings in Stevanato Group S.p.A. (NYSE:STVN) by 6.5% in the first quarter, HoldingsChannel.com reports. The fund owned 11,681 shares of the company’s stock after selling 814 shares during the quarter. First Bank & Trust’s holdings in Stevanato Group were worth $375,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. First Light Asset Management LLC boosted its stake in shares of Stevanato Group by 24.8% in the fourth quarter. First Light Asset Management LLC now owns 729,961 shares of the company’s stock worth $19,921,000 after acquiring an additional 145,206 shares during the period. Yorktown Management & Research Co Inc bought a new position in shares of Stevanato Group in the fourth quarter worth about $254,000. Trust Point Inc. bought a new position in shares of Stevanato Group in the fourth quarter worth about $252,000. Riverbridge Partners LLC boosted its stake in shares of Stevanato Group by 78.1% in the fourth quarter. Riverbridge Partners LLC now owns 1,274,805 shares of the company’s stock worth $34,789,000 after acquiring an additional 559,070 shares during the period. Finally, Sands Capital Management LLC lifted its position in shares of Stevanato Group by 1.6% in the fourth quarter. Sands Capital Management LLC now owns 1,884,330 shares of the company’s stock worth $51,423,000 after buying an additional 29,450 shares in the last quarter.

Wall Street Analysts Forecast Growth

STVN has been the topic of a number of research analyst reports. Morgan Stanley reiterated an “equal weight” rating and issued a $30.00 target price on shares of Stevanato Group in a research report on Monday, April 22nd. BNP Paribas initiated coverage on Stevanato Group in a research report on Monday, April 22nd. They issued an “outperform” rating on the stock. Finally, Stephens reiterated an “overweight” rating and issued a $38.00 target price on shares of Stevanato Group in a research report on Monday, March 25th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of €34.17 ($36.74).

Stevanato Group Stock Down 2.1 %

Shares of STVN stock opened at €18.34 ($19.72) on Friday. Stevanato Group S.p.A. has a 1 year low of €16.56 ($17.81) and a 1 year high of €36.30 ($39.03). The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.35 and a current ratio of 1.92. The stock’s 50 day simple moving average is €21.28 and its two-hundred day simple moving average is €26.85.

Stevanato Group (NYSE:STVN) last issued its quarterly earnings data on Thursday, May 9th. The company reported €0.09 ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of €0.12 ($0.13) by (€0.03) (($0.03)). Stevanato Group had a net margin of 12.57% and a return on equity of 12.61%. The company had revenue of €256.24 million for the quarter, compared to analysts’ expectations of €261.28 million. Equities research analysts anticipate that Stevanato Group S.p.A. will post 0.54 earnings per share for the current year.

Stevanato Group Announces Dividend

The business also recently disclosed an annual dividend, which will be paid on Monday, July 15th. Shareholders of record on Tuesday, June 4th will be given a dividend of $0.053 per share. The ex-dividend date of this dividend is Tuesday, June 4th. This represents a yield of 0.29%.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.